Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 27, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 26, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Cindy Motz Maintained (TDOC) at Strong Buy with Decreased Target to $55 on, May 26th, 2022
Cindy Motz of Goldman Sachs, Maintained "Teladoc Health, Inc." (TDOC) at Strong Buy with Decreased Target from $77 to $55 on, May 26th, 2022.
Cindy has made no other calls on TDOC in the last 4 months.
There are 21 other peers that have a rating on TDOC. Out of the 21 peers that are also analyzing TDOC, 13 agree with Cindy's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Eade of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, May 5th, 2022
- Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
- Daniel Grosslight of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $43 on, Thursday, April 28th, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $44 on, Thursday, April 28th, 2022
- Ryan Daniels of "William Blair" Downgraded from Buy to Hold on, Thursday, April 28th, 2022
- Sandy Draper of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, April 28th, 2022
- Stan Berenshteyn of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $40 on, Thursday, April 28th, 2022
- Stephanie Davis Demko of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
- Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $30 on, Thursday, April 28th, 2022
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $72 on, Tuesday, March 8th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $74 on, Wednesday, February 23rd, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $77 on, Wednesday, February 23rd, 2022
- Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
These are the ratings of the 8 analyists that currently disagree with Cindy
- Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Thursday, April 28th, 2022
- Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $48 on, Thursday, April 28th, 2022
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $65 on, Thursday, April 28th, 2022
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $104 on, Tuesday, March 8th, 2022
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $114 on, Friday, February 25th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $130 on, Wednesday, February 23rd, 2022
- Lisa Gill of "JP Morgan" Maintained at Buy with Decreased Target to $125 on, Wednesday, February 23rd, 2022
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
